Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [ 18 F]FDG PET/CT Imaging and Clinical Features.
Ine DirksMarleen KeyaertsIris DirvenBart NeynsJef VandemeulebrouckePublished in: Cancers (2023)
Automatically extracted TMTV based on whole-body [18F]FDG PET/CT can aid in building predictive models that can support therapeutic decisions in patients treated with immune-checkpoint blockade.